2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
4[1]Lai CL, Ching CK,Tung AKM,et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carders: A placebo-controlled trial. Hepatology, 1997,25:241. 被引量:1
5[2]Lai CL, Chien RN, Leung NWY, et al. One-year trial of lamivudine for chronic hepatitis B.N Eng J Med, 1998,339:61. 被引量:1
7Hsu CW,Thongsawat S,Wang Y,et al.Telbivudine versus lamivudine in patients with chronic hepatitis B[J].N Engl J Med,2007,357:2576-2588. 被引量:1
8Lai CL,Gane E,Hsu CW,et al.Two-year results from the GLOBE Trial in patients with hepatitis B:greater clinical and antiviral efficacy for telbivudine vs lamivudine[J].Hepatology,2006,44(4,Suppl1):222A. 被引量:1